[IgG antibody response against XXXX in @entity1 exposed to @entity311 , before and after specific treatment]

@entity1 @entity3172 @entity3965 @entity5895 @entity311
OBJECTIVE: To assess the IgG antibody response against P. vivax (IgG anti-PV), and cytophilic (IgG1 and @entity3172 ) and noncytophilic (IgG2) IgG subclasses in 34 @entity1 aged 0 to 15 years old infected with @entity3965 @entity311 . METHODS: IgG levels were determined by indirect fluorescent antibody technique during the acute and therapeutic control phase. @entity1 were distributed into 2 groups according to the presence or absence of a previous @entity311 episode. IgG anti-PV levels were measured on the first and last day of treatment, and compared by Studentacute;s t test. Antibody levels were correlated with @entity5895 (Spearma  s correlation test). RESULTS AND CONCLUSIONS: Increased IgG levels were observed on the first and on the last day of treatment. The geometric means for IgG subclass titers found in @entity1 with previous history of @entity311 were: IgG1 (806.35) > @entity3172 (28.28) > IgG2 (20). In @entity1 infected for the first time, the responses obtained were: IgG1 (709.21) > @entity3172 (39.3) > IgG2 (10.7). There was no association between @entity5895 and antibody levels on the first day of treatment. Cytophilic antibodies (IgG1, @entity3172 ) predominated over noncytophilic antibodies (IgG2).
